A vulnerability, which was classified as problematic, was found in IDEMIA SIGMA Lite, SIGMA Lite +, SIGMA Wide, SIGMA Extreme, MorphoWave Compact, XP, VisionPass and MorphoWave SP. Affected is an unknown function of the component Web Administration Interface. The manipulation with an unknown input leads to a cross site scripting vulnerability. CWE is classifying the issue as CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. This is going to have an impact on integrity. CVE summarizes:

The web interface of the PAC Device allows the device administrator user profile to store malicious scripts in some fields. The stored malicious script is then executed when the GUI is opened by any users of the webserver administration interface.  The root cause of the vulnerability is inadequate input validation and output encoding in the web administration interface component of the firmware. This could lead to  unauthorized access and data leakage

The weakness was presented 11/28/2023. The advisory is shared for download at idemia.com. This vulnerability is traded as CVE-2023-4667 since 08/31/2023. Successful exploitation requires user interaction by the victim. There are neither technical details nor an exploit publicly available. The MITRE ATT&CK project declares the attack technique as T1059.007.

There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.

Productinfo

Vendor

• IDEMIA

Name

• MorphoWave Compact
• MorphoWave SP
• SIGMA Extreme
• SIGMA Lite
• SIGMA Lite +
• SIGMA Wide
• VisionPass
• XP

CPE 2.3info

• 🔍
• 🔍
• 🔍

CPE 2.2info

• 🔍
• 🔍
• 🔍

CVSSv4info

CVSSv3info

CVSSv2info

Exploitinginfo

Threat Intelligenceinfo

Countermeasuresinfo

Timelineinfo

Sourcesinfo

Entryinfo

Discussion